Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2003-06-05
2009-06-02
Li, Q. Janice (Department: 1633)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023400, C536S024100, C435S069100, C435S320100, C424S093210
Reexamination Certificate
active
07541446
ABSTRACT:
The present invention provides a panel of transcriptional activator fusion proteins which comprises both tetracycline controlled transactivator proteins and reverse tetracycline transactivator proteins. These transactivators have novel phenotypes such as altered basal transcriptional activity in the absence of doxycycline, altered induced transcriptional activity in the presence of doxycycline, or differential induction by tetracycline and analogs of tetracycline.
REFERENCES:
patent: 5464758 (1995-11-01), Gossem et al.
patent: 5849576 (1998-12-01), Skerra et al.
patent: 5851796 (1998-12-01), Schatz
patent: 5917122 (1999-06-01), Byrne
patent: 6004941 (1999-12-01), Bujard et al.
patent: 6114148 (2000-09-01), Seed et al.
patent: 19851413 (2000-05-01), None
patent: 19851415 (2000-05-01), None
patent: WO 96/40892 (1996-12-01), None
Freundlieb et al, J Gene Med; 1999:1:4-12.
Wells et al, Transgenic Res 1999;8:371-81.
Urlinger et al, PNAS 2000;97:7963-8.
Kamper et al, FEBS lett 2002;517:115-20.
Krueger et al, Gene 2004:331:125-31.
Baron, U., et al., “Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential,”Nucleic Acids Res.Jul. 15, 1997;25(14):2723-9.
Baron, U., et al., “Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes,”Proc Natl Acad SciU S A. Feb. 2, 1999;96(3):1013-8.
Belli, G., et al., “Functional analysis of yeast essential genes using a promoter-substitution cassette and the tetracycline-regulatable dual expression system,”Yeast. Sep. 15, 1998;14(12):1127-38.
Belli, G., et al., “An activator/repressor dual system allows tight tetracycline-regulated gene expression in budding yeast,”Nucleic Acids Res.Feb. 15, 1998;26(4):942-7.
Bello, B., et al., “Spatial and temporal targeting of gene expression inDrosophilaby means of a tetracycline-dependent transactivator system,”Development. Jun. 1998;125(12):2193-202.
Bieschke, E.T., et al., “Doxycycline-induced transgene expression duringDrosophiladevelopment and aging,”Mol Gen Genet.Jun. 1998;258(6):571-9.
Camacho-Vanegas, O., et al., “Construction ofXenopus(B3.2) and human (HeLa) cell lines expressing the tetracycline-controlled transactivator,” In VitroCell Dev Biol Anim.Jan. 1998;34(1):14-5.
Colomina, N., et al., “G1 cyclins block the lme1 pathway to make mitosis and meiosis incompatible in budding yeast,”EMBO J.Jan. 15, 1999;18(2):320-9.
Deonarain, et al., “Ligand-targeted receptor-mediated vector for gene delivery,”Exp. Opin. Ther. Patents.1998; 8:53-59.
Eck, et al., “Gene-Based Therapy,”Goodman&Gillman's.1995; 9:77-101.
Efrat, S., et al., “Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene,”Proc Natl Acad Sci U S A.Apr. 11, 1995;92(8):3576-80.
Ewald, D., et al., “Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen,”Science. Sep. 6, 1996;273(5280):1384-6.
Fishman, G.I., et al., “Tetracycline-regulated cardiac gene expression in vivo,”J Clin Invest.Apr. 1994;93(4):1864-8.
Foster, K., et al., “Tetracycline-inducible expression systems with reduced basal activity in mammalian cells.”Nucleic Acids Research.1999;27(2):708-10.
Freundlieb, S., et al., “Use of tetracycline-controlled gene expression systems to study mammalian cell cycle,”Methods Enzymol.1997;283:159-73.
Furth, P.A., et al., “Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter,”Proc Natl Acad Sci U S A.Sep. 27, 1994;91(20):9302-6.
Gallego, C., et al., “The Cln3 cyclin is down-regulated by translational repression and degradation during the G1 arrest caused by nitrogen deprivation in budding yeast,”EMBO J.Dec. 1, 1997;16(23):7196-206.
Gari, E., et al., “A set of vectors with a tetracycline-regulatable promoter system for modulated gene expression inSaccharomyces cerevisiae,” Yeast. Jul. 1997;13(9):837-48.
Gatz, C., et al., “Tn10-encoded tet repressor can regulate an operator-containing plant promoter,”Proc Natl Acad Sci U S A. Mar. 1988;85(5):1394-7.
Gossen, M., et al., “Tight control of gene expression in mammalian cells by tetracycline-responsive promoters,”Proc Natl Acad Sci U S A. Jun. 15, 1992;89(12):5547-51.
Gossen, M., et al., “Transcriptional activation by tetracyclines in mammalian cells,”Science. Jun. 23, 1995;268(5218):1766-9.
Harding, T.C., et al., “Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system,”Nat Biotechnol.Jun. 1998;16(6):553-5.
Harvey, et al., “Inducib le control of gene expression: prospects for gene therapy,”Chemical Biology. 1998; 2:512-518.
Hecht, B., et al., “Noninducible Tet repressor mutations map from the operator binding motif to the C terminus,”J Bacteriol.Feb. 1993;175(4):1206-10.
Helbl, V., et al., “Stepwise selection of TetR variants recognizing tet operator 4C with high affinity and specificity,”J Mol Biol.Feb. 20, 1998;276(2):313-8.
Helbl, V., et al., “Stepwise selection of TetR variants recognizing tet operator 6C with high affinity and specificity,”J Mol Biol.Feb. 20, 1998;276(2):319-24.
Hillen, W., et al., “Mechanisms underlying expression of Tn10 encoded tetracycline resistance,”Annu Rev Microbiol.1994;48:345-69.
Hinrichs, W., et al., “Structure of the Tet repressor-tetracycline complex and regulation of antibiotic resistance,”Science. Apr. 15, 1994;264(5157):418-20.
Kisker, C., et al., “The complex formed between Tet repressor and tetracycline-Mg2+ reveals mechanism of antibiotic resistance,”J Mol Biol.Mar. 24, 1995;247(2):260-80.
Kistner, A., et al., “Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice,”Proc Natl Acad Sci U S A.Oct. 1, 1996;93(20):10933-8.
Muller, G., et al., “Characterization of non-inducible Tet repressor mutants suggests conformational changes necessary for induction,”Nat Struct Biol.Aug. 1995;2(8):693-703.
Nagahashi, S., et al., “Isolation ofCandida glabratahomologs of theSaccharomyces cerevisiaeKRE9 and KNH1 genes and their involvement in cell wall beta-1,6-glucan synthesis,”J Bacteriol. Oct. 1998;180(19):5020-9.
Nakayama, H., et al., “A controllable gene-expression system for the pathogenic fungusCandida glabrata,” Microbiology. Sep. 1998;144 ( Pt 9):2407-15.
Niedenthal, R.K., et al., “Green fluorescent protein as a marker for gene expression and subcellular localization in budding yeast,”Yeast. Jun. 30, 1996;12(8):773-86.
Oldenburg, K.R., et al., “Recombination-mediated PCR-directed plasmid construction in vivo in yeast,”Nucleic Acids Res.Jan. 15, 1997;25(2):451-2.
Orth, P., et al., “Conformational changes of the Tet repressor induced by tetracycline trapping,”J Mol Biol.Jun. 5, 1998;279(2):439-47.
Paulus, W., et al., “Regulated expression of the diphtheria toxin A gene in human glioma cells using prokaryotic transcriptional control elements,”J Neurosurg.Jul. 1997;87(1):89-95.
Schnappinger, D., et al., “Determinants of protein-protein recognition by four helix bundles: changing the dimerization specificity of Tet repressor,”EMBO J.Jan. 15, 1998;17(2):535-43.
Shockett, P., et al., “A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice,”Proc Natl Acad Sci USA.Jul. 3, 1995;92(14):6522-6.
Verma, et al., “Gene therapy-promises, problems and prospects,”Nature. Sep. 18, 1997; 389:239-242.
Wach, A., et al., “Heterologous HIS3 marker and GFP reporter modules for PCR-targeting inSaccharomyces cerevisiae,” Yeast. Sep. 15, 199
Bujard Hermann
Hillen Wolfgang
Urlinger Stefanie
Foley & Lardner LLP
Li Q. Janice
Tet Systems Holding GmbH & Co. KG
LandOfFree
Tet repressor-based transcriptional regulatory proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tet repressor-based transcriptional regulatory proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tet repressor-based transcriptional regulatory proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4088726